2Kario K. Morning surge in blood pressure and cardiovascularrisk: evidence and perspectives[EJ]. Hypertension, 2010,56 (5) :765-573.
3Kario K. Proposal of RAS-diuretic vs. RAS-calcium antagoniststrategies in high-risk hypertension: insight from the 24-hourambulatory blood pressure profile and central pressure[J]. J AmSoc Hypertens, 2010,4(5):215-218.
4Kario K,Hoshide S, Shimizu M, et al. Effect of dosing time ofangiotensin Ⅱ receptor blockade titrated by self-measured bloodpressure recordings on cardiorenal protection in hypertensives:the Japan Morning Surge-Target Organ Protection (J-TOP)study [J].J Hypertens, 2010,28(7):1574-1583.
5Matsui Y, Eguchi K, Shibasaki S, et al. Impact of arterialstiffness reduction on urinary albumin excretion duringantihypertensive treatment: the Japan morning surge-1 study[J].J Hypertens, 2010,28(8):1752-1760.
6Metoki H,Ohkubo T, Imai Y. Diurnal blood pressure variationand cardiovascular prognosis in a community-based study ofOhasama[J]. Japan Hypertens Res,2010,33(7) :652-656.
7Eguchi K, Hoshide S, Hoshide Y, et al. Reproducibility ofambulatory blood pressure in treated and untreated hypertensivepafients[J]. J Hypertens,2010,28(5) :918-924.
8Li Y, Thijs L, Hansen TW, et al. Prognostic value of themorning blood pressure surge in 5645 subjects from 8populations[J]. Hypertension, 2010,55 (4):. 1040-1048.
9Mancia G. Defining blood pressure goals: is it enough to managetotal cardiovascular risk? [J]. J Hypertens Suppl, 2009,27 (5) :S3-8.
10Li Y, Thijs L, Hansen TW, et al. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes investigators: prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations [ J ]. Hypertension, 2010,55 (4) : 1040-1048.
